glp 1 microdosing side effects GLP-1 for autoimmune conditions: what the research actually shows Should you microdose GLP-1 drugs?
Description
Mattina C
February 2, 2026: FDA Published Second Safety Label Change of 2026 for Zepbound Eli Lillys popular weight-loss drug Zepbound had a second safety label update in January 2026
However, widespread urticaria, mucosal involvement, or systemic symptoms such as dyspnea warrant immediate evaluation
Pomegranate Health pricing breakdown Pricing is where Pomegranate Health gets complicated
That data drives adjustments that prevent weight loss stalls on semaglutide and the frustrating weight gain that can happen on tirzepatide when nutrition falls apart
